title: Can we discontinue disease-modifying treatments in multiple sclerosis patients? No.
authors.affiliation: Hôpital de la Pitié-Salpêtrière, département des MSN, 47-83 boulevard de l'Hôpital, 75651 Paris cedex 13, France. Electronic address: caroline.papeix@psl.aphp.fr.
authors.forename: C
authors.initials: C
authors.lastname: Papeix
mesh_terms: D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D000069442:Natalizumab / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011256:Pregnancy Outcome; D012008:Recurrence; D012307:Risk Factors; D028761:Withholding Treatment
chemical_list: D007166:Immunosuppressive Agents; D000069442:Natalizumab
keywords: Intolerance; Multiple sclerosis; Pregnancy; Treatments